Nika Samadzadeh Tabrizi and Marc Gillinov/X
Oct 12, 2026, 21:30
Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
Nika Samadzadeh Tabrizi, Integrated Thoracic Surgery Resident at Cleveland Clinic, shared a post on X:
“Excellent talk by Marc Gillinov on the ongoing debate re: anticoagulation for POAF
- POAF often resolves within approximately 3 months
- Anticoagulation increases bleeding risk, without a clear survival advantage
Looking forward to PACeS trial to guide practice.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia
-
Oct 12, 2026, 19:27Melissa Hollo: Treating Anemia during Pregnancy Is an Investment in Two Generations of Health